Svl Life Science Profile
Key Indicators
- Authorised Capital ₹ 3.95 Cr
- Paid Up Capital ₹ 3.95 Cr
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 Cr
- Revenue Growth %
- Profit Growth -24.93%
- Ebitda -269.38%
- Net Worth
- Total Assets 8.76%
About Svl Life Science
Svl Life Science Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 October 2014 and has a history of Ten years and four months. Its registered office is in Vizianagaram, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.95 Cr and a paid-up capital of Rs 3.95 Cr.
The company currently has active open charges totaling ₹7.00 Cr.
Sanyasi Meesala, Thammu Pathivada, and Majji serve as directors at the Company.
Company Details
-
Location
Vizianagaram, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900AP2014PTC095451
-
Company No.
095451
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Oct 2014
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Svl Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanyasi Meesala
|
Director | 09-Oct-2014 | Current |
|
Thammu Pathivada
|
Director | 10-Nov-2016 | Current |
|
Majji
|
Director | 03-Jan-2021 | Current |
Financial Performance of Svl Life Science.
Svl Life Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 24.93% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svl Life Science?
In 2023, Svl Life Science had a promoter holding of 77.28% and a public holding of 22.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.00 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 7.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Oct 2018 | State Bank Of India | ₹7.00 Cr | Open |
How Many Employees Work at Svl Life Science?
Unlock and access historical data on people associated with Svl Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svl Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svl Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
